← Leaderboards

Italo Biaggioni

Vanderbilt University Medical Center

Google Scholar ↗PubMed ↗ORCID ↗

$17,539,936

Attributed

$18,850,304

Total exposure

40

Grants

25

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$23,244,434 · 42

By mechanism

R01$10,262,918 · 6

P01$7,182,419 · 9

U54$4,867,212 · 4

M01$931,885 · 23

Top collaborators

Luis Enrique Okamoto4 shared

Most similar at Vanderbilt University Medical Center

Same institution · by research overlap

Luis Enrique Okamoto$4,002,064

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchHuman SubjectNorepinephrineCardiovascular SystemBlood PressureHypertensionNitric OxideSympathetic Nervous SystemRegulationAutonomic Nervous SystemOrthostatic HypotensionResourcesImpairmentFunctional DisorderResearch PersonnelDesignBaroreflexAdenosineFundingPreventGuidelinesResidual StateCardiac OutputEffective Therapy

Grant awards (108)

Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension$671,690

R01 · FY2025 · HL · contact PI

Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension$660,375

R01 · FY2024 · HL · contact PI

Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension$671,588

R01 · FY2023 · HL · contact PI

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity$601,970

R01 · FY2023 · HL · contact PI

Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension$617,084

R01 · FY2022 · HL · contact PI

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity$601,971

R01 · FY2022 · HL · contact PI

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity$601,970

R01 · FY2021 · HL · contact PI

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity$601,970

R01 · FY2020 · HL · contact PI

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity$601,971

R01 · FY2019 · HL · contact PI

Autonomic Rare Diseases Clinical Research Consortium$1,250,001

U54 · FY2018 · NS · contact PI

Splanchnic Circulation and Blood Pressure Regulation$395,000

R01 · FY2018 · HL · contact PI

Project 2: Splanchnic Capacitance and Abnormal Blood Pressure Regulation in Autonomic Failure$195,014

U54 · FY2018 · NS · contact PI

Autonomic Rare Diseases Clinical Research Consortium - Datamining Supplement$69,236

U54 · FY2018 · NS · contact PI

Pilot Projects Program$57,743

U54 · FY2018 · NS · contact PI

Autonomic Rare Diseases Clinical Research Consortium$1,250,001

U54 · FY2017 · NS · contact PI

Splanchnic Circulation and Blood Pressure Regulation$395,000

R01 · FY2017 · HL · contact PI

Project 2: Splanchnic Capacitance and Abnormal Blood Pressure Regulation in Autonomic Failure$195,014

U54 · FY2017 · NS · contact PI

Pilot Projects Program$57,743

U54 · FY2017 · NS · contact PI

Splanchnic Circulation and Blood Pressure Regulation$41,080

R01 · FY2017 · HL · contact PI

Autonomic Cardiovascular Regulation$1,824,892

P01 · FY2016 · HL · contact PI

Splanchnic Circulation and Blood Pressure Regulation$392,500

R01 · FY2016 · HL · contact PI

Cardiovascular Regulations Autonomic/Metabolic Mechanisms$315,095

P01 · FY2016 · HL · contact PI

Clinical Core$222,734

P01 · FY2016 · HL · contact PI

Project 2: Splanchnic Capacitance and Abnormal Blood Pressure Regulation in Autonomic Failure$195,014

U54 · FY2016 · NS · contact PI

Pilot Projects Program$57,743

U54 · FY2016 · NS · contact PI

Splanchnic Circulation and Blood Pressure Regulation$392,500

R01 · FY2015 · HL · contact PI

Cardiovascular Regulations Autonomic/Metabolic Mechanisms$295,926

P01 · FY2015 · HL · contact PI

Clinical Core$232,900

P01 · FY2015 · HL · contact PI

Project 2: Splanchnic Capacitance and Abnormal Blood Pressure Regulation in Autonomic Failure$152,265

U54 · FY2015 · NS · contact PI

Pilot Projects Program$57,743

U54 · FY2015 · NS · contact PI

Cardiovascular Regulations Autonomic/Metabolic Mechanisms$330,854

P01 · FY2014 · HL · contact PI

Clinical Core$233,872

P01 · FY2014 · HL · contact PI

Cardiovascular Regulations Autonomic/Metabolic Mechanisms$268,063

P01 · FY2013 · HL · contact PI

project 2 - Autonomic Rare Diseases Clinical Research Consortium$251,111

U54 · FY2013 · NS · contact PI

Clinical Core$208,857

P01 · FY2013 · HL · contact PI

Cardiovascular Regulations Autonomic/Metabolic Mechanisms$315,095

P01 · FY2012 · HL · contact PI

project 2 - Autonomic Rare Diseases Clinical Research Consortium$274,860

U54 · FY2012 · NS · contact PI

Clinical Core$222,734

P01 · FY2012 · HL · contact PI

CARDIOVASCULAR REGUATIONS: AUTONOMIC/METBOLIC MECHANISMS$311,194

P01 · FY2011 · HL · contact PI

project 2 - Autonomic Rare Diseases Clinical Research Consortium$253,649

U54 · FY2011 · NS · contact PI

CLINICAL CORE$235,510

P01 · FY2011 · HL · contact PI

CARDIOVASCULAR REGUATIONS: AUTONOMIC/METBOLIC MECHANISMS$311,194

P01 · FY2010 · HL · contact PI

project 2 - Autonomic Rare Diseases Clinical Research Consortium$282,613

U54 · FY2010 · NS · contact PI

CLINICAL CORE$235,510

P01 · FY2010 · HL · contact PI

Autonomic Nervous System in Chronic Fatigue Syndrome$383,438

R01 · FY2009 · NS · contact PI

project 2 - Autonomic Rare Diseases Clinical Research Consortium$267,462

U54 · FY2009 · NS · contact PI

Autonomic Nervous System in Chronic Fatigue Syndrome$365,169

R01 · FY2008 · NS · contact PI

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$7,040

M01 · FY2008 · RR · contact PI

THE AUTONOMIC NERVOUS SYSTEM AND OBESITY$387

M01 · FY2008 · RR · contact PI

OXIDE AND AUTONOMIC MECHANISMS$305

M01 · FY2008 · RR · contact PI

ADENOSINE AND NITRIC OXIDE INTERACTION IN VASCULAR REGULATION$19

M01 · FY2008 · RR · contact PI

Autonomic Nervous System in Chronic Fatigue Syndrome$372,621

R01 · FY2007 · NS · contact PI

Cardiovascular Regulations: Autonomic/Metabolic Mechanisms$311,194

P01 · FY2007 · HL · contact PI

Clinical Core$235,510

P01 · FY2007 · HL · contact PI

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$149,430

M01 · FY2007 · RR · contact PI

THE AUTONOMIC NERVOUS SYSTEM AND OBESITY$8,205

M01 · FY2007 · RR · contact PI

OXIDE AND AUTONOMIC MECHANISMS$6,464

M01 · FY2007 · RR · contact PI

ADENOSINE AND NITRIC OXIDE INTERACTION IN VASCULAR REGULATION$257

M01 · FY2007 · RR · contact PI

Autonomic Nervous System in Chronic Fatigue Syndrome$382,500

R01 · FY2006 · NS · contact PI

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$285,664

M01 · FY2006 · RR · contact PI

OXIDE AND AUTONOMIC MECHANISMS$14,682

M01 · FY2006 · RR · contact PI

THE AUTONOMIC NERVOUS SYSTEM AND OBESITY$5,453

M01 · FY2006 · RR · contact PI

ADENOSINE AND NITRIC OXIDE INTERACTION IN VASCULAR REGULATION$839

M01 · FY2006 · RR · contact PI

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$166,715

M01 · FY2005 · RR

THE AUTONOMIC NERVOUS SYSTEM AND OBESITY$46,515

M01 · FY2005 · RR

OXIDE AND AUTONOMIC MECHANISMS$17,039

M01 · FY2005 · RR

Adenosine and Nitric Oxide Deficiency$264,250

R01 · FY2004 · HL

Etiology and Pathophysiology of Autonomic Failure$166,710

M01 · FY2004 · RR

Role of Adenosine and Nitric Oxide on the Mechanism of Action of Aggrenox$19,807

M01 · FY2004 · RR

The Autonomic Nervous System and Obesity$18,156

M01 · FY2004 · RR

Oxide and Autonomic Mechanisms .$17,056

M01 · FY2004 · RR

Adenosine and nitric oxide interaction in vascular regulation$550

M01 · FY2004 · RR

Adenosine and Nitric Oxide Deficiency$264,250

R01 · FY2003 · HL

PHARMACOLOGIC PROBES IN NEURALLY-MEDIATED SYNCOPE$227,250

R01 · FY2003 · HL

Adenosine and Nitric Oxide Deficiency$264,396

R01 · FY2002 · HL

PHARMACOLOGIC PROBES IN NEURALLY-MEDIATED SYNCOPE$227,250

R01 · FY2002 · HL

CARDIOVASCULAR REGULATION--AUTONOMIC/METABOLIC MECHANISMS$189,695

P01 · FY2002 · HL

CORE--ANALYTICAL$98,738

P01 · FY2002 · HL

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$0

M01 · FY2002 · RR

NITRIC OXIDE IN AUTONOMIC FAILURE$0

M01 · FY2002 · RR

RENAL DENERVATION IN ORTHOSTATIC INTOLERANCE$0

M01 · FY2002 · RR

ADENOSINE A2B RECEPTORS IN HUMAN MAST CELLS$0

M01 · FY2002 · RR

ADENOSINE IN EXERCISE PRESSOR REFLEX$0

M01 · FY2002 · RR

Adenosine and Nitric Oxide Deficiency$265,125

R01 · FY2001 · HL

CARDIOVASCULAR REGULATION--AUTONOMIC/METABOLIC MECHANISMS$200,479

P01 · FY2001 · HL

CORE--ANALYTICAL$200,479

P01 · FY2001 · HL

NITRIC OXIDE IN AUTONOMIC FAILURE$0

M01 · FY2001 · RR

RENAL DENERVATION IN ORTHOSTATIC INTOLERANCE$0

M01 · FY2001 · RR

RENAL DENERVATION IN ORTHOSTATIC INTOLERANCE$0

M01 · FY2001 · RR

RENAL DENERVATION IN ORTHOSTATIC INTOLERANCE$0

M01 · FY2001 · RR

ADENOSINE A2B RECEPTORS IN HUMAN MAST CELLS$0

M01 · FY2001 · RR

ADENOSINE A2B RECEPTORS IN HUMAN MAST CELLS$0

M01 · FY2001 · RR

ADENOSINE A2B RECEPTORS IN HUMAN MAST CELLS$0

M01 · FY2001 · RR

ADENOSINE IN EXERCISE PRESSOR REFLEX$0

M01 · FY2001 · RR

ADENOSINE IN EXERCISE PRESSOR REFLEX$0

M01 · FY2001 · RR

ADENOSINE IN EXERCISE PRESSOR REFLEX$0

M01 · FY2001 · RR

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$0

M01 · FY2001 · RR

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$0

M01 · FY2001 · RR

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$0

M01 · FY2001 · RR

NITRIC OXIDE IN AUTONOMIC FAILURE$0

M01 · FY2001 · RR

NITRIC OXIDE IN AUTONOMIC FAILURE$0

M01 · FY2001 · RR

CORE--ANALYTICAL$190,947

P01 · FY2000 · HL

CARDIOVASCULAR REGULATION--AUTONOMIC/METABOLIC MECHANISMS$190,947

P01 · FY2000 · HL

RENAL DENERVATION IN ORTHOSTATIC INTOLERANCE$592

M01 · FY2000 · RR

ADENOSINE A2B RECEPTORS IN HUMAN MAST CELLS$0

M01 · FY2000 · RR

ADENOSINE IN EXERCISE PRESSOR REFLEX$0

M01 · FY2000 · RR

ETIOLOGY AND PATHOPHYSIOLOGY OF AUTONOMIC FAILURE$0

M01 · FY2000 · RR

NITRIC OXIDE IN AUTONOMIC FAILURE$0

M01 · FY2000 · RR